# A Study of AB-1005 Gene Therapy in Japanese Adults With Moderate Parkinson's Disease

> **NCT07566429** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Bayer** · enrollment: 8 (estimated)

## Conditions studied

- Parkinson Disease

## Interventions

- **DRUG:** AB-1005

## Key facts

- **NCT ID:** NCT07566429
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-27
- **Primary completion:** 2028-12-15
- **Final completion:** 2032-06-15
- **Target enrollment:** 8 (ESTIMATED)
- **Last updated:** 2026-05-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07566429

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07566429, "A Study of AB-1005 Gene Therapy in Japanese Adults With Moderate Parkinson's Disease". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT07566429. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*